Promising combo therapy for brain metastases in lung cancer patients

NCT ID NCT06304441

First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 33 times

Summary

This study tests whether adding a chemotherapy drug (pemetrexed) given directly into the spinal fluid to a standard targeted therapy pill (like osimertinib) works better than the pill alone for lung cancer that has spread to the brain and spine. About 100 adults with a specific gene mutation (EGFR) are being recruited. The goal is to see if the combination improves response and survival while monitoring side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LEPTOMENINGEAL METASTASIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • The Third People's Hospital of Huizhou (Huizhou Hospital of Guangzhou Medical University)

    RECRUITING

    Huizhou, Guangdong, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.